Key Takeaways Emerging research suggests that diabetes and weight-loss drugs targeting GLP-1 and GIP receptors could help reduce binge drinking and improve liver health. Genetic studies provide early evidence that activating these receptors may lower alcohol consumption and protect against alcohol-related complications. Semaglutide, a GLP-1 receptor agonist, has shown preliminary results in reducing alcohol cravings, […]
The post Diabetes Drugs Show Promise in Alcohol Use Disorder appeared first on Nova Recovery Center Near Austin Texas.
More...
The post Diabetes Drugs Show Promise in Alcohol Use Disorder appeared first on Nova Recovery Center Near Austin Texas.
More...